Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC
Apply
Enfortumab Vedotin
Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step